DALLAS, Jan. 20, 2010 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biopharmaceutical company NeoStem Inc. (AMEX:NBS). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
The full report is available at: http://www.beaconequity.com/i/NBS
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/BeaconEquity
NeoStem Inc. (NBS) provides adult stem cell collection, processing and banking services in the United States. Through its acquisition of China Biopharmaceutical Holdings Inc., the Company develops products and services relating to adult stem cells as well as provides global research and development for commercialization of its novel technologies.
In the report, the analyst notes:
“The Company operates in a field of the stem cell sector independent of embryonic stem cell research, which is riddled with regulatory, ethical and technical issues. The adult stem cell sector is unburdened by these factors and unaffected by issues relating to tissue compatibility. The adult stem cells sector includes researchers and scientists, pharmaceutical and biotechnology companies presently engaged in the development of therapies for the treatment of various human pathologies. The Company stated that as these technologies receive regulatory approval and are accepted as standard of care, the medical community will need a service to collect and store patient stem cells.
“In 2009, the Company initiated expanded operations in China to establish storage, processing, as well as research and development facilities in China. Through the Company's recent acquisition of China Biopharmaceutical Holdings Inc., it intends to expand its services throughout major cities in the People's Republic of China. … The Company believes that these activities will advance its business within the China market.”
To read the entire report visit: http://www.beaconequity.com/i/NBS
See what investors are saying about NBS at penny stock forum.
BeaconEquity.com is one of the industry's largest small-cap report providers striving to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on Beacon Research, please visit http://www.BeaconEquity.com
Beacon Equity Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Beacon Equity nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.